Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
暂无分享,去创建一个
Aya Kamaya | Ahmed El Kaffas | A. Kamaya | Aman Khurana | Aman Khurana | A. El Kaffas | Amir M Pirmoazen | Amir M. Pirmoazen
[1] T. Yamanaka,et al. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. , 2016, Gastroenterology.
[2] T. Therneau,et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.
[3] E. Lawitz,et al. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study , 2005, BMC gastroenterology.
[4] Yoosoo Chang,et al. Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population , 2013, The American Journal of Gastroenterology.
[5] Alex A. T. Bui,et al. Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content , 2018, Theranostics.
[6] Marco Salvatore,et al. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. , 2009, Metabolism: clinical and experimental.
[7] Ronald H. Silverman,et al. Ultrasonic spectrum analysis for tissue assays and therapy evaluation , 1997, Int. J. Imaging Syst. Technol..
[8] Paulo R. S. Mendonça,et al. Contrast-Independent Liver-Fat Quantification from Spectral CT Exams , 2013, MICCAI.
[9] S. Curley,et al. Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.
[10] Jaap Stoker,et al. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis. , 2017, Radiology.
[11] Hsiang-Yang Ma,et al. Acoustic structure quantification by using ultrasound Nakagami imaging for assessing liver fibrosis , 2016, Scientific Reports.
[12] K. Cusi,et al. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association , 2012, The American Journal of Gastroenterology.
[13] D. Brenner,et al. Magnetic resonance elastography vs. transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease , 2017 .
[14] W. O’Brien,et al. Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease , 2018, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[15] Chien-Cheng Chang,et al. Using ultrasound Nakagami imaging to assess liver fibrosis in rats. , 2012, Ultrasonics.
[16] R. Stolk,et al. Ultrasonography to Quantify Hepatic Fat Content: Validation by 1H Magnetic Resonance Spectroscopy , 2009, Obesity.
[17] R. Fisher,et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values , 2003, Hepatology.
[18] Aijaz Ahmed,et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. , 2015, Gastroenterology.
[19] A. Feldstein,et al. Cytokeratin‐18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study , 2009, Hepatology.
[20] M. Reiser,et al. Material differentiation by dual energy CT: initial experience , 2007, European Radiology.
[21] M. Manns,et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. , 2018, Journal of hepatology.
[22] K. Clément,et al. Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data , 2012, PloS one.
[23] Hiroyuki Hachiya,et al. A pilot approach for quantitative assessment of liver fibrosis using ultrasound: preliminary results in 79 cases. , 2006, Journal of hepatology.
[24] A. Gamst,et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. , 2013, Radiology.
[25] Shuicai Wu,et al. Hepatic Steatosis Assessment Using Quantitative Ultrasound Parametric Imaging Based on Backscatter Envelope Statistics , 2019, Applied Sciences.
[26] H. Toyoda,et al. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction. , 2019, AJR. American journal of roentgenology.
[27] C. Lackner. Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist’s perspective , 2011, Expert review of gastroenterology & hepatology.
[28] Kouichi Itoh,et al. A new method for measuring the speed of sound in rat liver ex vivo using an ultrasound system: correlation of sound speed with fat deposition. , 2014, Ultrasound in medicine & biology.
[29] V. Wong,et al. Controlled attenuation parameter using the FibroScan® XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population , 2017, United European gastroenterology journal.
[30] Hiroyuki Hachiya,et al. B-mode ultrasound with algorithm based on statistical analysis of signals: evaluation of liver fibrosis in patients with chronic hepatitis C. , 2009, AJR. American journal of roentgenology.
[31] Sang Won Lee,et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.
[32] R. Jeffrey,et al. Intra-Individual Comparison between 2-D Shear Wave Elastography (GE System) and Virtual Touch Tissue Quantification (Siemens System) in Grading Liver Fibrosis. , 2017, Ultrasound in medicine & biology.
[33] C. Sirlin,et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[34] Nik Raihan Nik Mustapha,et al. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease , 2014, Journal of gastroenterology and hepatology.
[35] John M. Reid,et al. Analysis and measurement of ultrasound backscattering from an ensemble of scatterers excited by sine‐wave bursts , 1973 .
[36] C. R. Hill,et al. Acoustic properties of normal and cancerous human liver-II. Dependence of tissue structure. , 1981, Ultrasound in medicine & biology.
[37] Kouichi Itoh,et al. A New Method for Attenuation Coefficient Measurement in the Liver , 2002, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[38] G. Marchesini,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.
[39] Y. Takikawa,et al. Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude. , 2012, World journal of gastroenterology.
[40] L. Katsnelson,et al. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. , 2007, AJR. American journal of roentgenology.
[41] Thomas Deffieux,et al. Robust sound speed estimation for ultrasound-based hepatic steatosis assessment , 2017, Physics in medicine and biology.
[42] Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease. , 2017, Medical engineering & physics.
[43] K. Itoh,et al. Studies on frequency‐dependent attenuation in the normal liver and spleen and in liver diseases, using the spectral‐shift zero‐crossing method , 1988, Journal of clinical ultrasound : JCU.
[44] Haim Azhari,et al. Feasibility study of ultrasonic fatty liver biopsy: texture vs. attenuation and backscatter. , 2004, Ultrasound in medicine & biology.
[45] Chih-Kuang Yeh,et al. Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease , 2016, Scientific Reports.
[46] H. Garg,et al. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. , 2018, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[47] Rohit Loomba,et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.
[48] W. O’Brien,et al. Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD , 2019, European Radiology.
[49] M. Chammas,et al. Ultrasound Elastography: Review of Techniques and Clinical Applications , 2017, Theranostics.
[50] K. Cusi,et al. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. , 2014, Journal of hepatology.
[51] A. fong,et al. Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[52] Vandana Khungar,et al. Diagnostic accuracy of hepatorenal index in the detection and grading of hepatic steatosis , 2016, Journal of clinical ultrasound : JCU.
[53] C. Byrne,et al. NAFLD: a multisystem disease. , 2015, Journal of hepatology.
[54] G. Czarnota. Role of ultrasound in the detection of apoptosis , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[55] Hsiang-Yang Ma,et al. Effects of fatty infiltration in human livers on the backscattered statistics of ultrasound imaging , 2015, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.
[56] Yin-Yin Liao,et al. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome , 2018, Entropy.
[57] T. Berg,et al. Non-Invasive Assessment of Hepatic Steatosis in Patients with NAFLD Using Controlled Attenuation Parameter and 1H-MR Spectroscopy , 2014, PloS one.
[58] D. S̆timac,et al. Transient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? , 2016, World journal of gastroenterology.
[59] Minh Do,et al. In-vivo study of quantitative ultrasound parameters in fatty rabbit livers , 2012, 2017 IEEE International Ultrasonics Symposium (IUS).
[60] Lisa M Yerian,et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease , 2006, Hepatology.
[61] Li Ying,et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracy , 2014, Journal of gastroenterology and hepatology.
[62] S. W. Smith,et al. Phase aberration correction in medical ultrasound using speckle brightness as a quality factor. , 1989, The Journal of the Acoustical Society of America.
[63] Ching-Hua Chou,et al. Sound speed correction in ultrasound imaging. , 2006, Ultrasonics.
[64] B. Choi,et al. Hepatic steatosis in living liver donor candidates: preoperative assessment by using breath-hold triple-echo MR imaging and 1H MR spectroscopy. , 2014, Radiology.
[65] Takamichi Murakami,et al. Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Experimental Validation. , 2017, Radiology.
[66] Michael C. Kolios,et al. Quantitative ultrasound characterization of cancer radiotherapy effects in vitro. , 2008, International journal of radiation oncology, biology, physics.
[67] Minh N. Do,et al. Spectral-based quantitative ultrasound imaging: A model free approach , 2018 .
[68] R. Torella,et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. , 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[69] C. Kuni,et al. Correlation of Fourier spectral shift‐determined hepatic acoustic attenuation coefficients with liver biopsy findings. , 1989, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[70] Brian W. Anthony,et al. Quantitative Hepatic Fat Quantification in Non-alcoholic Fatty Liver Disease Using Ultrasound-Based Techniques: A Review of Literature and Their Diagnostic Performance. , 2018, Ultrasound in medicine & biology.
[71] Rita J. Miller,et al. Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound. , 2019, Ultrasound in medicine & biology.
[72] Xiaoping Hu,et al. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique. , 2009, Radiology.
[73] J. Zagzebski,et al. Accuracy of Liver Fat Quantification With Advanced CT, MRI, and Ultrasound Techniques: Prospective Comparison With MR Spectroscopy. , 2017, AJR. American journal of roentgenology.
[74] W. O’Brien,et al. Inter-sonographer reproducibility of quantitative ultrasound outcomes and shear wave speed measured in the right lobe of the liver in adults with known or suspected non-alcoholic fatty liver disease , 2018, European Radiology.
[75] V. Wong,et al. Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease , 2016, Journal of gastroenterology and hepatology.
[76] D. Rubens,et al. Shear wave dispersion measures liver steatosis. , 2012, Ultrasound in medicine & biology.
[77] V. de Lédinghen,et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. , 2010, Ultrasound in medicine & biology.
[78] Meng-Su Zeng,et al. Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method , 2011, Obesity.
[79] J. Jang,et al. Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease , 2016, PloS one.
[80] Erick M Remer,et al. The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[81] M. Tanter,et al. Investigating liver stiffness and viscosity for fibrosis, steatosis and activity staging using shear wave elastography. , 2015, Journal of hepatology.
[82] D. H. Lee,et al. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification , 2017, Clinical and molecular hepatology.
[83] E. Feleppa,et al. Relationship of Ultrasonic Spectral Parameters to Features of Tissue Microstructure , 1987, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[84] Eliseo Guallar,et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.
[85] L. Wilson,et al. Measurement of velocity of propagation from ultrasonic pulse-echo data. , 1982, Ultrasound in medicine & biology.
[86] K. Cusi,et al. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease , 2015, Hepatology.
[87] D E Robinson,et al. Clinical Sound Speed Measurement in Liver and Spleen in Vivo , 1987, Ultrasonic imaging.
[88] J. Bruzzi,et al. Liver biopsy. , 2001, The New England journal of medicine.
[89] Claude B Sirlin,et al. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. , 2018, The British journal of radiology.
[90] L. Castéra,et al. Non-invasive diagnosis of hepatic steatosis , 2016, Hepatology International.
[91] Michael C. Kolios,et al. Ultrasonic spectral parameter characterization of apoptosis. , 2002, Ultrasound in medicine & biology.
[92] Laurent Castera,et al. Non-invasive evaluation of liver fibrosis using transient elastography. , 2008, Journal of hepatology.
[93] L. Sandrin,et al. Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. , 2016, Ultrasound in medicine & biology.
[94] Ernest J. Feleppa,et al. Ultrasonic spectrum analysis for tissue evaluation , 2003, Pattern Recognit. Lett..
[95] C. Sirlin,et al. Optimal threshold of controlled attenuation parameter with MRI‐PDFF as the gold standard for the detection of hepatic steatosis , 2018, Hepatology.
[96] S. Horgan,et al. Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. , 2011, Radiology.
[97] Zamir Halpern,et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. , 2009, AJR. American journal of roentgenology.
[98] F. Tacke,et al. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis , 2019, Hepatology.
[99] J. Stoker,et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis , 2010, European Radiology.
[100] K. Nightingale,et al. Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging , 2015, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
[101] Manuel Romero-Gómez,et al. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. , 2018, Journal of hepatology.
[102] Osamu Maenishi,et al. Multimaterial Decomposition Algorithm for the Quantification of Liver Fat Content by Using Fast-Kilovolt-Peak Switching Dual-Energy CT: Clinical Evaluation. , 2017, Radiology.
[103] Rohit Loomba,et al. A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. , 2017, AJR. American journal of roentgenology.
[104] L. X. Yao,et al. Backscatter Coefficient Measurements Using a Reference Phantom to Extract Depth-Dependent Instrumentation Factors , 1990, Ultrasonic imaging.
[105] P. Mohana Shankar,et al. A general statistical model for ultrasonic backscattering from tissues , 2000, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[106] Ming-de Lu,et al. Assessment of liver fibrosis in chronic hepatitis B using acoustic structure quantification: quantitative morphological ultrasound , 2016, European Radiology.
[107] Jonathan Mamou,et al. Review of Quantitative Ultrasound: Envelope Statistics and Backscatter Coefficient Imaging and Contributions to Diagnostic Ultrasound , 2016, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.
[108] Jae Young Lee,et al. Hepatic Steatosis: Assessment with Acoustic Structure Quantification of US Imaging. , 2016, Radiology.
[109] G. Chartrand,et al. MRI‐determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes , 2016, Journal of magnetic resonance imaging : JMRI.
[110] J A Zagzebski,et al. Ultrasound backscatter and attenuation in human liver with diffuse disease. , 1999, Ultrasound in medicine & biology.
[111] H. Busse,et al. Estimating steatosis and fibrosis: Comparison of acoustic structure quantification with established techniques. , 2015, World journal of gastroenterology.
[112] V. Wong,et al. Can the same controlled attenuation parameter cut‐offs be used for M and XL probes for diagnosing hepatic steatosis? , 2018, Journal of gastroenterology and hepatology.
[113] J A Zagzebski,et al. Quantitative Ultrasound Imaging: in Vivo Results in Normal Liver , 1993, Ultrasonic imaging (Print).
[114] C. Riely,et al. Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. , 1986, Radiology.
[115] B. Neuschwander‐Tetri,et al. Vibration‐Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[116] Anthony Gamst,et al. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.